As of 12:40:17 PM GMT+11. Market Open.
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-44,741.0000
-48,458.0000
-63,269.0000
-65,782.0000
--
Operating Cash Flow
--
-48,458.0000
-63,269.0000
-65,782.0000
-100,749.0000
Investing Cash Flow
53.0000
-97.0000
-194.0000
-232.0000
-1,647.0000
Financing Cash Flow
41,534.0000
40,252.0000
74,502.0000
-9,870.0000
108,534.0000
End Cash Position
50,023.0000
62,960.0000
71,318.0000
60,447.0000
136,881.0000
Capital Expenditure
-185.0000
-331.0000
-314.0000
-232.0000
-1,647.0000
Issuance of Capital Stock
65,406.0000
65,406.0000
88,635.0000
209.0000
106,268.0000
Issuance of Debt
--
--
--
51,919.0000
--
Repayment of Debt
--
-13,522.0000
-2,656.0000
-58,246.0000
-2,931.0000
Free Cash Flow
-44,926.0000
-48,789.0000
-63,583.0000
-66,014.0000
-102,396.0000
6/30/2021 - 12/14/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MNPR Monopar Therapeutics Inc.
22.22
+1.00%
OCC.AX Orthocell Limited
1.4550
+0.34%
ARQT Arcutis Biotherapeutics, Inc.
14.56
+4.52%
KOD Kodiak Sciences Inc.
8.62
-13.37%
IMM.AX Immutep Limited
0.3670
+3.38%
NEU.AX Neuren Pharmaceuticals Limited
12.15
-0.82%
IMU.AX Imugene Limited
0.0400
+2.56%
BOT.AX Botanix Pharmaceuticals Limited
0.4570
+1.56%
CU6.AX Clarity Pharmaceuticals Ltd
4.0900
+0.74%
TLX.AX Telix Pharmaceuticals Limited
23.94
+0.40%